Sha Liu

1.0k total citations
39 papers, 815 citations indexed

About

Sha Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sha Liu has authored 39 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Sha Liu's work include Lung Cancer Treatments and Mutations (5 papers), Advanced Drug Delivery Systems (5 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Sha Liu is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Advanced Drug Delivery Systems (5 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Sha Liu collaborates with scholars based in China, United States and South Korea. Sha Liu's co-authors include Kaoxiang Sun, Hongjie Mu, Aiping Wang, Zimei Wu, Robert O. Williams, Wanhui Liu, Chenchen Bi, Youxin Li, Yongchao Chu and Xiaoyan Lu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Tetrahedron.

In The Last Decade

Sha Liu

35 papers receiving 804 citations

Peers

Sha Liu
Jeong Uk Choi South Korea
Dae Hwan Shin South Korea
Duhyeong Hwang United States
Chang Su China
Melissa D. Howard United States
Wenwen Du China
Jeong Uk Choi South Korea
Sha Liu
Citations per year, relative to Sha Liu Sha Liu (= 1×) peers Jeong Uk Choi

Countries citing papers authored by Sha Liu

Since Specialization
Citations

This map shows the geographic impact of Sha Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sha Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sha Liu more than expected).

Fields of papers citing papers by Sha Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sha Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sha Liu. The network helps show where Sha Liu may publish in the future.

Co-authorship network of co-authors of Sha Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Sha Liu. A scholar is included among the top collaborators of Sha Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sha Liu. Sha Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Dingkang, Sha Liu, Hairui Bai, et al.. (2025). Transcriptomic combined physiological analysis illuminated the gastrointestinal stress mechanism of Saccharomyces boulardii. Food & Function. 16(16). 6391–6400.
2.
Huang, Yaqin, Jiazhong Shi, Xiaozhou Zhou, et al.. (2025). XPC Deficiency Activate Cisplatin‐Mediated Autophagy in Bladder Cancer by Limiting Novel PHRF1‐Mediated Ubiquitination of the p53 Protein. Advanced Science. 13(5). e17563–e17563.
3.
Du, Yanhong, Yao Gao, Xinzhe Du, et al.. (2025). Further elucidation of GMPPB as a risk gene for depression through integrative multi-omics analyses. Journal of Affective Disorders. 384. 23–46.
4.
Liang, Tingting, Sha Liu, Jing‐Kai Huang, et al.. (2025). Metabolic and functional analyses reveal the stress tolerance network in Saccharomyces boulardii during gastrointestinal challenge. LWT. 237. 118754–118754.
5.
Hu, Wei, Xinzhe Du, Junxia Li, et al.. (2025). Explore autophagy-related lncRNA-miRNA-mRNA ceRNA networks for diagnosis of early-onset schizophrenia through transcriptome analysis. Frontiers in Psychiatry. 16. 1567148–1567148. 2 indexed citations
7.
Zhang, Yuan, Guangming Song, Jie Liu, et al.. (2023). Influence of konjac glucomannan and its derivatives on the oral pharmacokinetics of antimicrobial agent in antibiotics cocktails: Keep vigilant on dietary fiber supplement. International Journal of Biological Macromolecules. 251. 126306–126306. 2 indexed citations
9.
Wang, Long, Sha Liu, Jiesi Luo, et al.. (2022). Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia. Haematologica. 108(5). 1394–1411. 9 indexed citations
10.
Liu, Sha, Yiying Sun, Ying Li, et al.. (2022). Tanshinone IIA-Loaded Micelles Functionalized with Rosmarinic Acid: A Novel Synergistic Anti-Inflammatory Strategy for Treatment of Atherosclerosis. Journal of Pharmaceutical Sciences. 111(10). 2827–2838. 9 indexed citations
11.
Liu, Sha, et al.. (2022). Combination of Bevacizumab and Osimertinib in Patients with EGFR T790M-Mutated Non-small Cell Lung Cancer. Clinical Drug Investigation. 42(5). 459–464. 3 indexed citations
12.
13.
Zhang, Qingfei, Shasha He, Gaizhen Kuang, et al.. (2020). Morphology tunable and acid-sensitive dextran–doxorubicin conjugate assemblies for targeted cancer therapy. Journal of Materials Chemistry B. 8(31). 6898–6904. 22 indexed citations
14.
Qian, Liqiang, Liyun Ji, Sha Liu, et al.. (2020). Affinity chromatography assisted comprehensive phosphoproteomics analysis of human saliva for lung cancer. Analytica Chimica Acta. 1111. 103–113. 24 indexed citations
15.
Lu, Xiaoyan, Sha Liu, Xiucheng Yang, et al.. (2019). Afatinib-loaded immunoliposomes functionalized with cetuximab: A novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer. International Journal of Pharmaceutics. 560. 126–135. 49 indexed citations
16.
Shang, Zhi, Xiaomin Niu, Kewei Zhang, et al.. (2019). FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma. Journal of Molecular Medicine. 97(12). 1657–1668. 9 indexed citations
17.
Lu, Xiaoyan, et al.. (2018). Determination of tyrosine kinase inhibitor afatinib in rat plasma using LC–MS/MS and its application to in vivo pharmacokinetic studies of afatinib liposomes. Journal of Pharmaceutical and Biomedical Analysis. 164. 181–186. 15 indexed citations
18.
Zhang, Xuemei, Hongjie Mu, Qingqing Meng, et al.. (2018). RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy. International Journal of Pharmaceutics. 543(1-2). 179–189. 59 indexed citations
19.
Liu, Sha, et al.. (2015). Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 96. 132–142. 7 indexed citations
20.
Watts, Alan B., et al.. (2014). Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats. European Journal of Pharmaceutics and Biopharmaceutics. 88(1). 136–147. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026